Search details
1.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 777-789, 2021 Aug 26.
Article
in English
| MEDLINE | ID: mdl-34351722
2.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Article
in English
| MEDLINE | ID: mdl-34351721
3.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med
; 384(16): 1491-1502, 2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33631065
4.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA
; 329(1): 39-51, 2023 01 03.
Article
in English
| MEDLINE | ID: mdl-36525245
5.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA
; 329(14): 1183-1196, 2023 04 11.
Article
in English
| MEDLINE | ID: mdl-37039790
6.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(13): 1247-1259, 2022 04 05.
Article
in English
| MEDLINE | ID: mdl-35315874
7.
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
JAMA
; 324(13): 1317-1329, 2020 10 06.
Article
in English
| MEDLINE | ID: mdl-32876697
8.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Intensive Care Med
; 47(8): 867-886, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34251506
Results
1 -
8
de 8
1
Next >
>>